In the BioHarmony Drug Report Database

"Preview" Icon

Amlodipine besilate

Amlodipine Besylate, Norvasc (amlodipine besylate) is a small molecule pharmaceutical. Amlodipine besylate was first approved as Amlodipine Besylate on 1992-07-31. It is used to treat coronary artery disease, hypertension, and variant angina pectoris in the USA. It is known to target voltage-dependent L-type calcium channel subunit alpha-1D and voltage-dependent L-type calcium channel subunit alpha-1C. Norvasc’s patent is valid until 2022-11-20 (FDA).


Trade Name


Amlodipine Besylate, Norvasc

Common Name


amlodipine besylate






coronary artery disease, hypertension, variant angina pectoris

Drug Class


Phenylpyridine vasodilators (nifedipine type)

Image (chem structure or protein)

Amlodipine besilate structure rendering